CP137437671 | FDA panel debates booster for single-dose vaccine

CP137360871 | FDA panel backs lower-dose Moderna COVID booster

CP138908121 | FDA panel backs Pfizer's COVID-19 vaccine for kids

CP138845871 | FDA panel reviews Pfizer's COVID vaccine for kids

CP137329422 | FDA panel debates lower-dose Moderna COVID booster

CP137447922 | FDA panel questions Janssen data in booster debate

CP139022171 | California Gov. Newsom gets vaccine booster shot

CP138236322 | CDC panel backs booster expansion despite concerns

CP128212922 | WHO calls for moratorium on vaccine booster shots

CP153540072 | FDA: 50 and up can get 2nd Pfizer, Moderna booster

FDA panel endorses booster for single-shot vaccine

A panel of U.S. health advisers has endorsed booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine. The FDA panel said Friday that the booster should be offered at least two months after immunization but didn't suggest a firm time. (Oct. 15)

Source name:

Unique identifier: CP137449971

Legacy Identifier: 7b694e1541964532b80027cb6e20adcc

Type: Video

Duration: 35s

Dimensions: 1920px × 1080px 43.65 MB

Usage rights: Digital platform use only. Broadcast rights and editing of content prohibited.

Create Date: 10/15/2021 2:25:05 PM

Display aspect ratio: 16:9